3rd Apr 2017 15:56
Block Listing Six Monthly Return
Information provided on this form must be typed or printed electronically and provided to an RIS.
Date: 3 April 2017
Name of applicant: | Hikma Pharmaceuticals PLC | |||
Name of scheme: | Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP") & Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP") & Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("MIP") & Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP") | |||
Period of return | From: | 1 October 2016 | To: | 31 March 2017 |
Balance of unallotted securities under scheme(s) from previous return: | SOP: 792,700 ordinary shares of 10 pence LTIP: 305,031 ordinary shares of 10 pence MIP: 111,007 ordinary shares of 10 pence EIP: 0 ordinary shares of 10 pence | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | SOP: 0 ordinary shares of 10 pence LTIP: 121,000 ordinary shares of 10 pence MIP: 200,000 ordinary shares of 10 pence EIP: 379,000 ordinary shares of 10 pence | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | SOP: 0 ordinary shares of 10 pence LTIP: 35,940 ordinary shares of 10 pence MIP: 393 ordinary shares of 10 pence EIP: 14,394 ordinary shares of 10 pence | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | SOP: 792,700 ordinary shares of 10 pence LTIP: 390,091 ordinary shares of 10 pence MIP: 310,614 ordinary shares of 10 pence EIP: 364,606 ordinary shares of 10 pence | |||
Name of contact: | Peter Speirs |
Telephone number of contact: | 0207 399 2772 |
Stock Option Plan ("SOP") | ||||
Date | Block Listing | Shares Issued | Balance (Headroom) | Notes |
01/10/2016 | - | - | 792,700 | Blocklisting return on 01/10/16 |
01/04/2017 | - | - | 792,700 | Blocklisting return on 01/04/17 |
Long Term Incentive Plan ("LTIP") | ||||
Date | Block Listing | Shares Issued | Balance (Headroom) | Notes |
01/10/2016 | - | - | 305,031 | Blocklisting return on 01/04/16 |
10/10/2016 | 0 | 6,463 | 298,568 | |
23/10/2016 | 121,000 | 0 | 419,568 | |
08/11/2016 | 0 | 5,565 | 414,003 | |
10/11/2016 | 0 | 7,964 | 411,147 | |
14/11/2016 | 0 | 6,463 | 399,576 | |
09/01/2017 | 0 | 5,000 | 394,576 | |
17/03/2017 | 0 | 4,485 | 390,091 | |
01/04/2017 | - | - | 390,091 | Blocklisting return on 01/04/17 |
Management Incentive Plan ("MIP") | ||||
Date | Block Listing | Shares Issued | Balance (Headroom) | Notes |
01/10/2016 | - | - | 111,007 | Blocklisting return on 01/10/16 |
23/10/2016 | 200,000 | 0 | 311,007 | |
16/02/2016 | 0 | 393 | 310,614 | |
01/04/2017 | - | - | 310,614 | Blocklisting return on 01/04/17 |
Executive Incentive Plan ("EIP") | ||||
Date | Block Listing | Shares Issued | Balance (Headroom) | Notes |
01/10/2016 | - | - | 111,007 | |
23/10/2016 | 379,000 | 0 | 379,000 | |
04/01/2017 | 0 | 7,775 | 371,225 | |
05/01/2017 | 0 | 3,713 | 367,512 | |
17/02/2017 | 0 | 2,906 | 364,606 | |
01/04/2017 | - | - | 364,606 | Blocklisting return 01/04/17 |
Related Shares:
Hikma Pharmaceuticals